Denise M: Precision Hemostasis in Patient Blood Management
Denise M, Bloodless Medicine and Surgery Program Coordinator, shared a post on LinkedIn:
“Sometimes the best work begins with a challenge.
A few weeks ago, I posted an infographic on the value of Patient Blood Management (PBM) during a crisis.
Tomaz Crochemore, critical care physician and hemostasis expert, left a comment that stopped me.
He said the infographic was outstanding.
Then he pushed further. He wanted to see Patient Clot Management and precision hemostatic medicine explicitly woven into the PBM framework.
It was the first time I had heard of Patient Clot Management. While the physiology of bleeding and thrombosis including conditions like DIC is familiar territory in clinical practice, the term Patient Clot Management was new to me.
Crochemore’s work gave language and structure to that complexity.
I visited his profile (who is this guy?), and found his just published article in the Juntendo Medical Journal:
‘Revisiting the Concept of DIC: A Phenotype-guided Framework for Modern Hemostatic Medicine.’ That was my a-ha moment.
The dynamic balance between bleeding and thrombosis. Coagulopathy phenotyping. Individualized hemostatic therapy.
He was right. So I went to work.
What emerged is this:
Precision Hemostasis in Patient Blood Management.
A framework that moves beyond anemia and transfusion stewardship into the full spectrum of blood health:
- Identifying coagulopathy phenotypes — sepsis, trauma, cancer, obstetric, ECMO-induced
- Matching therapy to the patient’s actual hemostatic state
- Preventing both bleeding AND thrombosis
Not one-size-fits-all. Precision-guided. Patient at the center.
For me, it expanded how I think about the PBM framework and adds another dimension to the PBM conversation
Thank you, Crochemore, for seeing further and for trusting that a PBM nurse coordinator in Brooklyn would follow you there. It was great collaborating with you.
This infographic is proof. LinkedIn made it possible. ”

Stay updated with Hemostasis Today.
-
Mar 15, 2026, 13:57Abdulrahman Nasiri: D14 Bone Marrow Biopsy in AML Induction in the Era of Targeted Therapies
-
Mar 15, 2026, 13:52Valentin Ortiz-Maldonado: High-Impact Innovation in CAR-T Therapy Can Emerge From Academic Programmes
-
Mar 15, 2026, 13:45Tareq Abadl: Has Anyone Here Ever Taken an ALP Test Before?
-
Mar 14, 2026, 21:30Ayman Elbadawi: Why Does Stent Thrombosis Still Occur? Insights from the NCDR Data
-
Mar 14, 2026, 20:03Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency
-
Mar 14, 2026, 19:28Vishnu Priya Pulipati: Statins Beyond Cholesterol for Plaque Biology and Cardiovascular Risk Reduction
-
Mar 14, 2026, 19:19Yunpeng Xue: Humbled and Honored to Receive the 2025 Eberhard F. Mammen Young Investigator Award
-
Mar 14, 2026, 19:13Abhilasha Singh: A Novel Mechanism of Cardiac Aging and Disruption of The Neurovascular Network
-
Mar 14, 2026, 19:08Saleh Owimer: The Critical Rules of Safe Blood Transfusion